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ABSTRACT 
 If exercise is initiated when insulin remains elevated from a pre-exercise meal, some 
individuals may experience a brief period of hypoglycemia 15-30 min into exercise.  
Rebound hypoglycemia is a consequence of increased glucose uptake by skeletal muscle and 
suppressed hepatic glucose production.  The impact of pre-exercise carbohydrate ingestion 
on endurance exercise performance remains unclear.  Amylomaize-7, a type of high amylose 
corn starch, evokes a smaller insulin response than dextrose and therefore could be a better 
pre-exercise carbohydrate.  The purposes of this study were to 1) use a strategically timed 
high intensity cycling trial to detect possible performance impairment caused by a 
carbohydrate preload, and 2) compare metabolic response and exercise performance when 
amylomaize-7 versus dextrose is consumed in the hour before exercise. 
 Ten trained cyclists (VO2max of 64.6 ± 1.8 ml/kg/min) were given 1 g/kg body mass 
of either dextrose or amylomaize-7 or a sugar-free flavored water placebo 45 min prior to 
exercise on a cycle ergometer.  A 15 min ride at 60% Wmax was immediately followed by a 
self-paced time trial with a workload equivalent to 15 min at 80% Wmax (264 ± 12 KJ).   
 Time required to complete the performance trial was not significantly different 
between treatments (p = 0.209).  In the dextrose trial, serum glucose concentrations increased 
from 5.8 ± 0.1 mM to 9.1 ± 0.6 mM before exercise.  By the end of the TT, glucose had 
decreased to 5.5 ± 0.4 mM – significantly lower than placebo and starch (p < 0.05).  The 
insulin concentration was also significantly elevated at pre-exercise, but was no different 
than placebo by the start of the TT.  Serum insulin and glucose concentrations for the starch 
trial were the same as placebo for all time points. Affect scale ratings, RPE, and 
questionnaire responses did not reveal significant differences between treatments.  In 
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conclusion, pre-exercise ingestion of amylomaize-7 instead of dextrose results in more stable 
serum glucose and insulin concentrations, but does not offer an additional performance 
advantage. 
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CHAPTER 1. INTRODUCTION 
Carbohydrate ingestion during prolonged exercise has been shown to improve 
performance by maintaining blood glucose levels (4).  Carbohydrate ingestion after exercise 
has been shown to speed recovery by promoting glycogen resynthesis (19).  However, 
carbohydrate ingestion before exercise has shown mixed effects on endurance performance; 
in some studies it was improved (11), in others it was impaired (9,25), and in others it was 
unaffected (15,20,21,31).  The conflicting results have been attributed to differences in study 
design such as the carbohydrate type, amount, or timing; exercise intensity or duration; 
subject training status; and performance testing method. 
After a large carbohydrate load, blood glucose rises steeply, stimulating insulin 
secretion by the pancreas.  Insulin promotes cellular uptake of glucose via GLUT4 
translocation.  Skeletal muscle contractions also promote GLUT4 movement to the cell 
membrane (39).  When the start of exercise coincides with peaking insulin levels (30-60 min 
after carbohydrate consumption), the synergistic effect of insulin and exercise can cause a 
rapid decline in blood glucose to baseline levels or below (7).  Rebound hypoglycemia, as it 
has been termed, has been a recent area of research because it is unclear why some 
individuals are more susceptible to the transient hypoglycemia and to what extent it affects 
endurance performance (20,21,22). 
Low molecular mass carbohydrates such as sucrose, dextrose, and glucose polymers 
are often used in carbohydrate supplements because of their high digestibility and water 
solubility (41).  However, rapid entry of glucose into the blood leads to a large insulin 
release, which may predispose an athlete to hypoglycemia at the onset of 
exercise.  Alternative carbohydrate types, such as corn starch, have been proposed as a way 
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to moderate the metabolic response by providing a more slowly digested source of glucose 
(3).  The rate of starch digestion is largely determined by the relative proportion of 
amylopectin and amylose it contains (12).  Amylopectin has a highly branched chemical 
structure, making it more susceptible to enzymatic degradation.  Amylose is more slowly 
digested because its linear configuration limits enzymatic access and permits hydrogen 
bonding between molecules (26).  Most cereal starches are 80% amylopectin and 20% 
amylose (12).  After Guezennec et al. (14) found that pure corn starch consumed before 
exercise offered no advantage over dextrose, Seewi et al. (34) determined that a minimum of 
30% amylose content is necessary to attenuate postprandial insulin responses.   
There are certain corn genotypes that naturally contain a higher percentage of 
amylose.  Amylomaize has a 70% amylose content (41).  It has been shown to lower insulin 
response by 42% (12), a desirable trait for a pre-exercise carbohydrate source.  Unmodified 
high amylose corn starch is not regularly used in carbohydrate supplements because it is only 
68% digestible (14) and insoluble in cold water (41).  However, high amylose corn starch can 
be partially hydrolyzed with hydrochloric acid and alcohol, producing amylomaize-7, which 
is 92% digestible and readily soluble in water (41).  With these physical characteristics and a 
chemical structure that suppresses insulin secretion, amylomaize-7 may be a better pre-
exercise carbohydrate than rapidly absorbed carbohydrates like dextrose. 
To test the effect of rebound hypoglycemia on exercise performance or detect benefits 
from substituting amylomiaze-7 for dextrose as a pre-exercise carbohydrate, an appropriate 
cycling time trial protocol must be selected.   The majority of previous studies have utilized a 
time to exhaustion trial at a fixed workload (9,15,25,28) or a submaximal pre-load ride 
followed by a maximal time trial (1,11,21,22,29,30).  Jeukendrup et al. (23) showed that time 
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to exhaustion trials have poor reproducibility, making this type of test insensitive to small 
changes caused by a nutritional intervention.  Protocols with lengthy submaximal pre-load 
rides are also inappropriate for testing the effects of rebound hypoglycemia because the 
rebound hypoglycemia may be resolved by the time the performance task is begun. 
Hargreaves et al. found that after pre-exercise dextrose ingestion, blood glucose 
concentration declined significantly 15 min into exercise, but was no different from the 
placebo by 30 min (15).  If a time trial is undertaken 60 min into exercise, counterregulatory 
hormones will have already normalized blood glucose levels, and observation of performance 
impairment would be unlikely.  A better way to detect even a brief detrimental effect caused 
by rebound hypoglycemia is to introduce a high intensity time trial directly during the 
hypoglycemic period.  
It is important to understand the impact of the hypoglycemia on performance and 
determine if amylomaize-7 can prevent it from occurring because if an athlete is required to 
exert a sudden burst of energy early in a competition (e.g., a cyclist encountering a hill), 
valuable seconds could be lost, which could ultimately decide the winner of the race.  The 
purposes of this study are to 1) use a strategically timed high intensity cycling trial to detect 
possible performance impairment caused by a carbohydrate preload, and 2) compare 
metabolic response and exercise performance when amylomaize-7 versus dextrose is 
consumed in the hour before exercise.  It is hypothesized that pre-exercise carbohydrate 
ingestion will not affect exercise performance, and that substitution of amylomaize-7 for 
dextrose as the carbohydrate source will result in a more stable plasma glucose concentration 
in the first 30 min of exercise. 
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CHAPTER 2. LITERATURE REVIEW 
Introduction 
 Exercise physiology research literature contains numerous studies on carbohydrate 
ingestion and exercise performance.  The results of studies on carbohydrate supplementation 
during and after exercise are mostly in agreement, whereas those on carbohydrate ingestion 
before exercise are not.  This literature review first outlines the current knowledge 
concerning pre-exercise carbohydrate ingestion.  Then, glucose and insulin kinetics are used 
to explain why rebound hypoglycemia may be observed in people who consume 
carbohydrate in the hour before exercise.  The influence of starch structure on digestion and 
insulin response is discussed, along with the benefits of starch modification.  Finally, the 
need for designing a specific cycling protocol for testing performance after a pre-exercise 
carbohydrate load is presented. 
Carbohydrate and Exercise 
Carbohydrate feedings during exercise have been shown to improve endurance 
performance by maintaining blood glucose (4).  Consuming carbohydrate in the two h 
following exercise has been shown to speed glycogen resynthesis (19).  Ingestion of 
carbohydrate in the hour before exercise has been shown to impair (9,25), improve (11), or 
have no effect on (15,20,21,31) endurance exercise performance.   
Two older studies by Foster et al. (9) and Keller and Schwarzkopf (25) are the most 
commonly cited examples of impaired performance following a pre-exercise carbohydrate 
load.  Foster et al. (9) observed a 19% reduction in time to exhaustion when subjects (8 
males, 8 females) were given 75 g of dextrose 30 min before exercising at 80% VO2max.  
Pre-exercise carbohydrate ingestion, and subsequent elevation of insulin levels during 
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exercise, resulted in a significantly lower free fatty acid concentration during the cycling 
bout.  Blood samples collected 10 min into exercise revealed a period of transient 
hypoglycemia (<3.5 mM) in the carbohydrate group; however, plasma glucose 
concentrations at exhaustion were similar to those who consumed only water before exercise.  
Although three subjects reported symptoms of hypoglycemia just before stopping the ride, 
because blood lactate concentration was low and fatigue was primarily isolated to the 
quadriceps femoris, glycogen depletion rather than hypoglycemia was blamed for the 
performance decline.   
Similarly, Keller and Schwarzkopf (25) found that subjects (five male collegiate 
distance runners) who consumed 100 g of dextrose 60 min before exercise on a cycle 
ergometer had a 25% shorter time to exhaustion compared to subjects who consumed a 
placebo.  The exercise was continuously repeated high intensity intervals: 85% VO2max for 
two min, separated by a one min rest.  Post-exercise plasma glucose levels were similar for 
both groups, but blood lactate was 23% higher in the carbohydrate group.  It was concluded 
that impaired fatty acid mobilization and increased glycogen utilization likely caused the 
premature fatigue in the subjects who consumed dextrose before exercise.    
Glycogen depletion could not be confirmed in either of these studies because no 
muscle biopsies were taken.  The exercise intensities of these trials were higher than those 
employed in more recent research.  This may be one reason why few, if any, other studies 
have been able to detect performance impairment caused by pre-exercise carbohydrate.   
A trial by Goodpaster et al. (11) found pre-exercise carbohydrate actually improved 
the endurance performance of ten male competitive cyclists.  Subjects were provided 1 g/kg 
body mass of dextrose, waxy starch, resistant starch, or placebo 30 min before a 90 min 
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submaximal preload ride (66% VO2max) and 30 min time trial.  Dextrose improved time trial 
performance by 8% and waxy starch improved it 6%.  Serum glucose and insulin were 
significantly higher in the dextrose group at the start of exercise, but after 15 min there were 
no differences between any of the treatments.  The authors surmised that pre-exercise 
carbohydrate provided an ergogenic effect by providing additional carbohydrate for oxidation 
when glycogen stores were depleted by the lengthy preload ride.   
Research by Hargreaves et al. (15), in which muscle biopsies were taken, showed that 
pre-exercise dextrose caused more fluctuations in plasma glucose and insulin levels early in 
exercise, but had no effect on endurance performance or glycogen use.  Subjects in the study 
were given 75 g of dextrose, fructose, or placebo 45 min prior to a ride to exhaustion at 75% 
VO2max.  Blood glucose fell rapidly at the onset of exercise in the dextrose trial, and 
remained significantly different from the placebo until 15 min.  However, there were no 
differences in plasma glucose at exhaustion, which was reached at approximately 90 min in 
all three treatments.  The exercise-ending fatigue must have been caused by factors other 
than glycogen depletion because subjects had as much as 50 to 55 mmol/kg wet wt of 
glycogen remaining in their muscles. 
One of the most extensive investigations of pre-exercise carbohydrate and 
performance was carried out in the Human Performance Laboratory at the University of 
Birmingham (1,20,21,22,31).  In their systematic research series, the investigators showed 
that time trial performance was not affected by pre-exercise carbohydrate ingestion 
regardless of carbohydrate timing (15, 45, 75 min pre-exercise), load (0, 25,75, 200g 
dextrose), type (trehalose, galactose, dextrose), or exercise intensity (40%, 65%, 80% 
VO2max).  Unless otherwise specified, the protocol of each study was the same: a 75g 
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carbohydrate load was given to 8-10 endurance trained males 45 min prior to a 20 min 
submaximal preload ride (65-75% VO2max), followed by a time trial.  The lack of agreement 
in the scientific literature regarding pre-exercise carbohydrate ingestion has often been 
attributed to the wide variation in study designs.  By standardizing the research protocol, 
researchers at the University of Birmingham were able to compare results between trials.  
However, if some aspect of their standard design (e.g. cycling protocol) prevented a 
performance impairment from being detected, it would have been prevented in all the studies.    
Glucose and Insulin Kinetics 
After Eating 
 Normal fasting blood glucose is 3.9-5.5 mM.  When the concentration is elevated 
following a carbohydrate meal, the pancreas secretes insulin, a hormone stimulating cellular 
uptake of glucose.  In adipose and skeletal muscle cells, insulin causes translocation of 
GLUT4, a glucose transport protein, from intracellular pools to the plasma membrane.  High 
insulin levels also suppress lipolysis and hepatic glucose production.  Plasma insulin peaks 
30-60 min after a meal, depending on the amount and structure of the carbohydrate 
consumed (3,34).  There appears to be a dose-response relationship between the carbohydrate 
load and the amount of insulin secreted (35,39). 
During Exercise 
Although exercise suppresses pancreatic insulin production, cellular uptake of 
glucose increases during exercise because muscle contractions also cause GLUT4 
translocation (39).  In the fasted state, hepatic glycogenolysis and gluconeogenesis maintain 
plasma glucose levels during exercise until glycogen stores are exhausted (4). 
Eating and Exercising: Rebound Hypoglycemia 
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If exercise is undertaken when insulin levels are still elevated from a pre-exercise 
carbohydrate meal, some individuals may experience a rapid decline in plasma glucose to 
baseline levels or below during the first 10-30 min of exercise.  This phenomenon, known as 
rebound hypoglycemia, does not occur in everyone, but appears to be more common at 
moderate intensities and in trained individuals (39).  Although high insulin sensitivity, 
characteristic of trained individuals, would seem to be a logical predisposing factor for 
rebound hypoglycemia, Jentjens et al. (22) were unable to find an association between the 
two.  Due to the actions of counter-regulatory hormones, rebound hypoglycemia is short-
lived; plasma glucose concentration is usually normalized within the 20-30 min.  
It is important to note that the term hypoglycemia is not associated with a specific 
plasma glucose concentration.  In studies it has been defined as 2.5 mM (29), 3.5 mM 
(16,17), or anything below an individual’s resting blood glucose concentration (39).  
Rebound hypoglycemia is not a reflection of depleted glycogen stores; it is a consequence of 
increased glucose uptake and suppressed hepatic glucose production caused by residual 
insulin (27).   
Exercise and insulin appear to have a synergistic interaction, markedly increasing the 
rate of cellular glucose uptake, which can lead to the sharp decline in plasma glucose 
concentration at the start of exercise.  One study showed that glucose uptake was 55% higher 
than predicted if the actions of insulin and exercise were purely additive; together they 
increased leg glucose uptake 3-6 times more than one or the other alone (7).  In the study, 
DeFronzo et al. (7) first examined the effect of insulin by itself on glucose uptake.  Ten 
subjects were given a continuous infusion of insulin to raise the plasma concentration by 
~100µU/ml.  Since that dose completely suppresses splanchnic glucose production, the rate 
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of glucose uptake could be determined based on the amount of glucose provided by a glucose 
infusion pump.  Next, the effect of exercise alone on peripheral glucose uptake was 
measured.  Subjects cycled at 40% VO2max for 30 min while glucose concentrations were 
monitored using catheters inserted into the hepatic vein, femoral artery, and femoral vein.  
Then, the insulin infusion and exercise of the first two protocols were combined.  The 
authors concluded that increased extraction (via GLUT4 translocation by both insulin and 
muscle contraction) and increased blood flow (newly opened capillary beds exposing 
nonperfused muscle cells to insulin) caused the significant increase in glucose uptake.   
In the fasted state, a normal feed-forward activation of glucose production by the liver 
provides for the initial demands of exercise.  When this mechanism is blunted by insulin, 
short term hypoglycemia can ensue.  In an investigation by Marmy-Conus et al. (27), six 
trained men were given 75g of dextrose 30 min before an hour-long cycling bout at 71% 
VO2max.    At the onset of exercise, hepatic glucose production decreased in the 
carbohydrate group from ~12.5 µmol/kg to 1.0 ± 0.7 µmol/kg.  Ten min into exercise, hepatic 
glucose production of the carbohydrate group began increasing.  However, during the entire 
60 min of exercise, hepatic glucose production never exceeded pre-exercise levels and was 
reduced by 62% compared to the placebo group.   
Classic symptoms of hypoglycemia (e.g., headache, nausea, weakness, disorientation) 
have sometimes been reported by subjects experiencing rebound hypoglycemia (39), while 
others have been asymptomatic (20,21,30,35).  In their study on multiple pre-exercise 
carbohydrate feedings, Short et al. (39) reported “it was of interest that 2-3 of the subjects in 
each CHO treatment indicated that their legs felt somewhat ‘heavy’ or ‘fatigued’ during the 
first 30 min of exercise.  These individuals gradually regained their feeling of well-being and 
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were able to complete the entire ride.”  The cyclists’ blood glucose concentrations at this 
time were 2.1-2.9 mM, some of the lowest reported in pre-exercise carbohydrate literature.  
Although these findings suggest rebound hypoglycemia could temporarily impair endurance 
performance, no studies to date have been able to objectively demonstrate it. 
Type of Carbohydrate 
Structure and Digestion 
Low molecular mass carbohydrates such as sucrose, dextrose, and glucose polymers 
are often used in carbohydrate supplements because of their high digestibility and water 
solubility (41).  However, a large insulin release due to rapid entry of glucose into the blood 
may predispose an individual to hypoglycemia at the beginning of exercise.  Because of this, 
alternative carbohydrate types have been proposed as a way to moderate the metabolic 
response by providing a more slowly digested source of glucose (3).   
The rate of starch digestion is largely determined by the proportion of amylopectin 
and amylose it contains (3,12,32).  Amylopectin is a polysaccharide with a highly branched 
chemical structure, making it more susceptible to enzymatic degradation.  Amylose, on the 
other hand, is more slowly digested because its linear configuration limits enzymatic access 
and permits hydrogen bonding between molecules (2,26).  Most cereal starches are 80% 
amylopectin and 20% amylose (12).   
Corn Starch 
Guezennec et al. (14) tested corn starch as a pre-exercise carbohydrate, but found it 
offered no advantage over dextrose.  Six male subjects were given isocaloric amounts 
(~380kcal) of either dextrose or corn starch one hour before exercising at 60% VO2max for 
120 min.  Exogenous carbohydrate oxidation and glycemic/insulinemic responses during 
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exercise were the same for both carbohydrates.  In a later study by Seewi et al. (34), 26 
healthy volunteers consumed soups containing 30g of pea starch (34% amylose) or corn 
starch (24% amylose).  The results showed that a minimum of 30% amylose content is 
necessary to attenuate postprandial insulin responses. 
Modified High Amylose Corn Starch 
Amylomaize starch, the product of a unique corn hybrid, has a 70% amylose content 
and could be an excellent pre-exercise carbohydrate source.  Granfeldt et al. (12) prepared 
arepas (corn bread cakes) with either ordinary corn flour (25% amylose) or high amylose 
corn flour.  When nine subjects consumed the high amylose arepas, mean glucose response 
was reduced by 57% and insulin response by 42%.   Two different trials were conducted 
(meal mass matched for total starch or matched for digestible starch), so the researchers were 
able to conclude that the favorably low insulinemic response was caused by a slower rate of 
enzymatic digestion, not a lesser amount of potentially available starch.  This brings up an 
important point; unmodified high amylose corn starch is not regularly used in carbohydrate 
supplements because it is only 68% digestible (13) and insoluble in cold water (41).  
However, high amylose corn starch can be partially hydrolyzed with hydrochloric acid and 
alcohol, producing amylomaize-7, which is 92% digestible and readily soluble in water 
(41,38).   
Behall et al. (2) fed 25 subjects carbohydrate at 1g/kg body mass in the form of 
crackers made from regular (30% amylose) or high amylose corn starch.  Glucose levels 
peaked lower and fluctuated less from fasting levels in response to the high amylose 
crackers.  Consequently, the insulin levels were significantly lower in the hour after 
ingestion.  The researchers confirmed that the two starches were equally digested because 
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total glucose observed under the curves were equivalent.  In addition, Severijnen et al. (36) 
found that high amylose corn starch has good long-term stability and a gastric emptying rate 
comparable to maltodextrin.  Because of these favorable chemical and physical properties, 
amylomaize-7 may be a better pre-exercise carbohydrate than rapidly absorbed carbohydrates 
like dextrose. 
Cycling Protocols 
Time to Exhaustion vs. Time Trial 
Within-subject variability is inherent in exercise performance.  This variability can be 
further accentuated when subjects are exposed to unfamiliar surroundings, spectators, muscle 
biopsies, and blood draws.  Since carbohydrate ingestion before exercise has also been 
shown to have an unpredictable effect on exercise performance, selection of an appropriately 
sensitive performance measure is crucial for these trials.  Time to exhaustion tests have been 
frequently used to study the effects carbohydrate supplementation, but research by 
Jeukendrup et al. (23) suggests these may not be the most reliable.  Researchers compared 
the reproducibility of three different 60 min protocols (A: continuous ride at 75% VO2max to 
exhaustion, B: 45 min preload at 75% VO2max followed by a 15 min time trial, C: workload 
equivalent to one hour at ~75% VO2max to be completed as fast as possible).  Thirty well-
trained subjects were divided into groups of ten, and assigned one protocol to complete six 
times.  The exercise to exhaustion protocol displayed poor reproducibility – a coefficient of 
variation of 26.6%.  In contrast, protocols B and C had coefficients of variation of ~3.5%.  
Work by McConell et al. (28) confirmed these findings, but found time to exhaustion trials 
for subjects cycling at approximately the same intensity was only 12.1%.   
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Open-ended protocols may place more emphasis on psychological factors.  Indeed, 
Foster et al. (9) noted that compared to a short, fixed duration time trial, the point of 
exhaustion during an open-ended ride was “much more subjectively determined and was 
usually manifested as unwillingness on the part of the subject to continue the ride, rather than 
by a physical inability to turn the pedals.”  It appears a protocol with a fixed endpoint is less 
influenced by motivation or boredom, has a smaller coefficient of variation, and may be a 
more sensitive test for pre-exercise carbohydrate ingestion trials.  
A mixed design (steady preload followed by a time trial) is a useful protocol for 
supplementation studies because it allows time to monitor physiological responses and then 
test exercise performance.  Sewell et al. (37) showed that reproducibility of this kind of 
design is reasonably good: a coefficient of variation of 6.3% for recreationally active 
subjects.  Furthermore, since the time trial takes place late in the exercise, endogenous fuel 
sources will be reduced and the benefits a nutritional supplementation on endurance 
performance may be most apparent.  
Testing performance during rebound hypoglycemia  
Protocols with lengthy submaximal pre-load rides are inappropriate for testing the 
effects of rebound hypoglycemia because the hypoglycemia may be resolved by the time the 
performance task is begun.  After a pre-exercise carbohydrate load, blood glucose levels have 
been shown to decline significantly 15 min into exercise, but then return to baseline by 30 
min (11,15,17).  If a time trial is undertaken 60 min into exercise, when blood glucose has 
already been normalized, it is unlikely that any consequence of the rebound hypoglycemia 
would be detected.  Thus, a more appropriate protocol for a pre-exercise carbohydrate study 
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would include a high intensity time trial introduced directly during the hypoglycemic period 
(15-30 min into exercise). 
Conclusion 
Conflicting results regarding the effect of pre-exercise carbohydrate ingestion on 
performance (9,11,20) are likely due to differences in study design such as the carbohydrate 
type, amount, or timing; exercise intensity or duration; subject training status; and 
performance testing method.  Rebound hypoglycemia, a consequence of hyperinsulemia at 
the start of exercise, is commonly observed after pre-exercise carbohydrate ingestion, but has 
never been proven to impair performance.  However, no study has initiated a short, high 
intensity performance time trial during the hypoglycemic period (15-30 min into exercise).  
Since elevated insulin at the start of exercise is the cause of rebound hypoglycemia, a slowly 
digestible carbohydrate such as amylomaize-7, which evokes a smaller insulin release, may 
prevent rebound hypoglycemia from occurring in the first place. 
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CHAPTER 3. METHODS 
Subjects 
Ten male trained cyclists and triathletes 18-35 y with a minimum VO2max of 50 
ml/kg/min were recruited for the study.  Institutional Review Board approval and written 
informed consent were obtained before the trials.   
Exercise Protocol 
Each subject reported to the laboratory four times for the study.  All visits were 
conducted after a 12 hour overnight fast and separated by approximately one week.  They 
were told the purpose of the study was to observe how carbohydrate consumption affects 
endurance performance.  During the first visit, an incremental test to exhaustion on a Load 
Excaliber cycle ergometer (Groningen, Netherlands) was used to determine VO2max and 
Wmax.  The max test was designed to be completed in 10-14 min and was conducted 
according to ACSM guidelines (8). The initial workload of 100 W was increased by either 50 
W or 25 W every two min until the subject reached volitional exhaustion.  Revolutions per 
min were recorded at each stage to determine the subject's preferred cycling cadence.  
The following three visits were identical, except for the randomly assigned 
experimental beverage.  When the subject arrived, body mass and resting heart rate/blood 
pressure were obtained.  A flexible catheter was inserted into an antecubital vein and was 
kept patent with sterile isotonic saline after each blood draw.  The subject ingested one of 
three carbohydrate solutions before resting quietly for 45 min prior to exercise.   
For the first 15 min of the cycling bout, the Lode Excaliber was set to hyperbolical 
mode (RPM independent) at a workload equivalent to 60% Wmax.  At min 15, the cycle 
ergometer was switched into linear mode (RPM dependent) for the performance time trial: a 
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workload equivalent to 15 min at 80% Wmax.  During the time trial, the subject was not 
allowed to see the clock and did not receive any verbal encouragement other than a prompt at 
50% completion.  Thirty min of seated recovery followed the performance time trial. 
Beverage Contents 
The beverages provided 1g/kg body mass of either dextrose or amylomaize-7 starch 
dissolved in 400ml water.  The placebo contained only water.  The study was double-blind; 
subjects were told the beverages were different sports drinks.  All three drinks had added 
sugar-free orange Kool-Aid flavoring and were given to the subject in a lidded, opaque cup.  
An additional 100ml chaser of water was used to rinse residual carbohydrate from the cup.  
To prepare the amylomaize-7 starch, one kg of high amylose corn starch (Hylon VII – 
National Starch) was soaked in 1 L 100% ethanol and 100 ml hydrochloric acid for three 
days as described in the procedure of Sharp et al. (38). 
Physiological and Psychological Measurements 
Blood samples were collected pre-ingestion, pre-exercise, immediately before and 
after the performance time trial, and 30 min into recovery.  The samples were kept on ice, 
centrifuged at 3,000 RPMs for 20 min, and stored at -80° C until analyzed.  Serum glucose 
(Sigma HK assay, Beckman Spectrophotometer), insulin (Calbiotech ELISA, Fluostar plate 
reader), and lactate (Sigma colorimetric assay, Beckman Spectrophotometer) concentrations 
were measured in duplicate.  Two psychological affect scales were administered at the time 
of the first four blood draws: a feeling scale ranging from -5 (very bad) to +5 (very good) and 
an arousal scale ranging from 1 (low arousal) to 6 (high arousal).  The subjects’ rating of 
perceived exertion (from 6 to 20) was assessed before and after the performance time trial.  A 
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hypoglycemia symptom questionnaire from Hepburn et al. (16) was completed at baseline 
and immediately after the time trial. 
Statistical Analysis 
Serum variables were analyzed by two-way repeated measures analysis of variance 
(ANOVA) (time and treatment) using SigmaStat statistical software.  Performance was 
analyzed by one-way repeated measures ANOVA; treatment order was also used as a 
covariate to test for a significant effect of trial order.  Holm-Sidak post hoc tests were used to 
locate significant mean differences.  Psychological data were averaged because no treatment 
differences were observed.  All data are reported as mean ± SEM, n = 10.  Significant 
differences were determined at p < 0.05.   
Dietary and Exercise Control 
Subjects were asked to keep a three d food log prior to the first carbohydrate 
ingestion trial and to duplicate it before the following two visits.  They were asked to refrain 
from alcoholic beverages and strenuous exercise in the 24 h before each trial.  Maintenance 
of consistent training at their usual volume was encouraged throughout the study.    
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CHAPTER 4. RESULTS 
Subject Characteristics 
Subjects completed the four lab visits with a minimum of four and maximum of nine 
d between each.  Physical characteristics of the subjects are listed in Table 1. 
 
Table 1. Subject characteristics 
  
Age 21 ± 1 y 
Height 177 ± 2 cm 
Body Mass 71.8 ± 3.0 kg 
Body Mass Index 22.9 ± 0.5 kg/m2 
VO2max 64.6 ± 1.8 ml/kg/min 
Wmax 366 ± 16 W 
Values are mean ± SEM (n = 10) 
 
The self-reported dietary intake for three d prior to each experimental trial is listed in 
Table 2. The percentage of energy coming from carbohydrate was slightly lower than the 
Acceptable Macronutrient Distribution Range recommended by the Institute of Medicine for 
19 to 30 y males (45-60%, 10-35%, 20-35% for carbohydrate, protein, and fat, respectively) 
(18).  This was primarily due to one subject who reported consuming a low-carbohydrate diet 
(14% of total kcal).  Statistical analyses were conducted with and without this subject’s data.  
All conclusions regarding significant differences remained the same; therefore, his data was 
retained.    
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Table 2. Self-reported mean dietary intake for the three d prior to each experimental trial 
Macronutrient Daily Intake % Total Kcal 
Energy 2810 ± 136 kcal  
Carbohydrate 292 ± 29 g 43% 
Protein 165 ± 21 g 24% 
Fat 101 ± 10 g 33% 
Values are means ± SEM (n = 10) 
 
Time Trial Performance 
Time required to complete the workload of the performance trial was not significantly 
different between treatments (p=0.21).  However, in comparison to the placebo trial (PL), 
there was a tendency for subjects to complete the dextrose trial (DEX) slower and the starch 
trial (AMY-7) faster (Figure 1).  Analysis of performance with treatment order as a covariate 
revealed no significant effect of order. 
Metabolic Responses 
 There was a significant treatment-by-time interaction for serum glucose concentration 
(p < 0.001).  The pre-exercise and 30 min post-exercise concentrations within DEX were 
significantly higher than the pre-ingestion baseline.  Compared to PL, glucose concentration 
in DEX was significantly higher pre-exercise and 30 min post-TT, but significantly lower 
immediately post-TT (p < 0.05).  Glucose concentration in AMY-7 was not different than PL 
at any time point (p < 0.05) (Figure 2).  
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Figure 1. Time required to complete the workload of the cycling performance trial 
(mean ± SEM, n = 10).  Time trial performance was not significantly different 
between treatments (p = 0.209).
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Figure 2.  Change in serum glucose concentration after pre-exercise carbohydrate ingestion 
(mean SEM, n = 10).  There was a main effect of time (p < 0.001) and treatment-by-time 
interaction (p < 0.001), but no main effect of treatment (p = 0.164)
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Figure 2. Change in serum glucose concentration after pre-exercise carbohydrate ingestion 
(mean ± SEM, n = 10).  There was a main effect of time (p < 0.001) and treatment-by-time 
interaction (p < 0.001), but no main effect of treatment (p = 0.164).  * indicates a significant 
difference between treatments (p < 0.05); † indicates a significant difference from baseline  
(p < 0.05). 
Time (min) 
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Unsurprisingly, the pre-exercise serum insulin concentration was significantly higher 
in DEX, resulting in a main effect for treatment, time, and treatment-by-time interaction 
(p<0.001).  Insulin responses (increase from baseline) ranged from 0.8 µIU/ml to 33.4 
µIU/ml for individual subjects in the 45 min following dextrose ingestion.  Peak insulin 
response for AMY-7 compared to DEX was 1.5 ± 0.1 µIU/ml and 11.7 ± 3.2 µIU/ml, 
respectively.  By pre-TT, however, DEX was not different than PL (2.2 ± 0.3 µIU/ml and 1.3 
± 0.0 µIU/ml, respectively) (p = 0.907).  Serum insulin concentrations in AMY-7 were no 
different from PL at any time point (p < 0.05) (Figure 3).  
 There was a significant effect of time (p < 0.001) on serum lactate concentration, as 
well as a treatment-by-time interaction (p = 0.008).  Samples taken during exercise (pre-TT 
and post-TT) were significantly higher than non-exercising time points (p < 0.05).  Lactate 
concentration in DEX was significantly higher than PL at pre-TT (5.6mM  and 4.5mM, 
respectively) (p < 0.05).  In AMY-7, lactate concentration was 10% higher than both DEX 
and PL post-TT (p <0.05) (Figure 4). 
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Figure 3. Change in serum insulin concentration after pre-exercise carbohydrate 
ingestion (mean ± SEM, n = 10).  There were main effects of treatment (p < 0.001) and
time (p < 0.001) and treatment-by-time interaction (p < 0.001). * indicates a significant
difference between treatments (p < 0.001); † indicates a significant difference from all 
other time points (p <0.001).
†*
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Figure 4.  Change in serum lactate concentration after pre-exercise carbohydrate ingestion 
(Mean ± SEM, n = 10).  There was a main effect of time (p < 0.001) and trial-by-time
interaction (p = 0.008), but no main effect of treatment (p = 0.267).
Time (min)
0 15 30 45 60 75 90 105 120
Se
ru
m
 L
ac
ta
te
 (m
M
)
0
2
4
6
8
10
12
14
Dextrose
Placebo
Starch
* Starch significantly different from dextrose and placebo 
† Dextrose significantly different from placebo  p < 0.05
†*
SS Ex TT
†*
  
Figure 4. Change in serum lactate concentration after pre-exercise carbohydrate ingestion 
(mean ± SEM, n = 10).  There was a main effect of time (p < 0.001) and trial-by-time 
interaction (p = 0.008), but no main effect of treatment (p = 0.267).  * indicates a 
significant difference from placebo (p < 0.05); † indicates a significant difference from 
baseline (p < 0.05). 
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Psychological Indices 
 There were no differences in affect scale ratings between the treatments.  Rating of 
perceived exertion was higher post-TT than pre-TT (Table 3).   
 
Table 3. Psychological ratings 
 Pre-ingestion Pre-exercise Pre-TT Post-TT 
Feeling     
Dextrose 3 ± 1 3 ± 1 3 ± 1 1 ± 1 
Placebo 3 ± 0 3 ± 0 2 ± 0 1 ± 1 
Starch 3 ± 0 3 ± 0 3 ± 0 1 ± 0 
Arousal     
Dextrose 3 ± 0 3 ± 0 4 ± 0 4 ± 0 
Placebo 2 ± 0 3 ± 0 4 ± 0 5 ± 0 
Starch 3 ± 0 3 ± 0 4 ± 0 4 ± 0 
RPE     
Dextrose   12 ± 0 17 ± 0 
Placebo   12 ± 1 17 ± 0 
Starch   12 ± 0 17 ± 1 
Values are means ± SEM (n = 10) 
 
For five common hypoglycemia symptoms, mean ratings (on a scale of 1 to 7) did not 
increase more than one point between baseline and post-TT nor exceed a rating of three at 
any time for any treatment. (Table 4). 
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Table 4. Hypoglycemia questionnaire responses 
 Weakness Nausea Headache Dizziness Inability to 
Concentrate 
Dextrose      
Baseline 2 ± 0 1 ± 0 1 ± 0 1 ± 0 1 ± 0 
Post-TT 2 ± 0 1 ± 0 1 ± 0 1 ± 0 2 ± 0 
Placebo      
Baseline 2 ± 0 1 ± 0 1 ± 0 1 ± 0 1 ± 0 
Post-TT 3 ± 0 1 ± 0 1 ± 0 2 ± 0 1 ± 0 
Starch      
Baseline 2 ± 0 1 ± 0 1 ± 0 1 ± 0 1 ± 0 
Post-TT 3 ± 0 1 ± 0 1 ± 0 1 ± 0 2 ± 0 
Values are means ± SEM (n = 10) 
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CHAPTER 5. DISCUSSION 
As expected, cyclists began exercise hyperglycemic and hyperinsulinemic when they 
ingested dextrose 45 min prior to cycling.  The observed serum glucose and insulin response 
(3 mM and 10 µIU/ml increases, respectively) were comparable to a previous investigation 
done in this laboratory with an identical carbohydrate load (24).  After 15 min of exercise, 
the elevated glucose concentration returned to baseline due to enhanced glucose uptake and 
oxidation.  Muscle contractions cause GLUT4 translocation to the cell membrane, facilitating 
glucose transport (39).  Insulin acts synergistically with exercise to further increase cellular 
glucose uptake (7).  Insulin also reduces hepatic glucose production (27), suppresses lipolysis 
(17), and increases the rate of carbohydrate oxidation (5,11,24).   A 75 g pre-exercise 
dextrose load was shown to inhibit hepatic glucose production 62% during 60 min of 
exercise at 70% VO2max (26).  During a two hour cycling bout at 65% VO2max, total 
carbohydrate oxidation (measured via 13C isotopic ratio) was reportedly 21% higher when 1 
g/kg body mass of dextrose was consumed 30 min prior to exercise (24).  Carbohydrate 
oxidation was not directly assessed in the present study, but the significantly elevated serum 
lactate pre-TT in DEX (5.6 ± 0.7 mM DEX; 4.5 ± 0.6 mM PL), indicates increased glycolytic 
activity following hyperinsulinemia. 
Post-TT glucose concentration was significantly lower in DEX compared to PL and 
AMY-7 even though insulin was the same for all treatments by pre-TT.  The number of 
insulin receptors still bound or treatment differences in the rate of insulin disappearance 
during the first 15 min of exercise cannot be ascertained from that single measurement of 
serum concentration.  Insulin’s effects persist even after serum concentration has returned to 
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normal (29).  Because it is well established that pancreatic production of insulin dramatically 
decreases during exercise, post-exercise samples were not analyzed for insulin in the present 
study (7,11,15,35,39).  
Decreased metabolic demand from skeletal muscle and action of the 
counterregulatory hormones raised the glucose in DEX to above baseline and the other two 
treatments by 30 min into recovery.  Similar overcompensation has been observed 90 min 
after pre-exercise carbohydrate ingestion even when cyclists continued cycling (70% 
VO2max), suggesting glucagon, epinephrine, norepinephrine play primary roles in this 
occurrence (27). 
The serum glucose fluctuations observed in the present study parallel those in 
reported in other investigations on pre-exercise carbohydrate ingestion and rebound 
hypoglycemia (9,14,20,30,39).  However, glucose concentration did not drop low enough to 
meet the criteria for hypoglycemia.  The mean DEX post-TT concentration, although lower 
than PL and AMY-7, was not lower than DEX pre-ingestion baseline.  The lowest individual 
glucose concentration observed was 4.0 mM (pre-TT DEX) - still well above 2.5 mM or 3.5 
mM cited as diagnostic of hypoglycemia (20,21,35).  Several subjects verbally reported 
dizziness at the conclusion of the DEX TT, but the symptoms were not reflected in the RPE, 
affect scales, or hypoglycemia questionnaire responses.  Short et al. (39) described similar 
complaints of “heaviness” and “fatigue” from subjects with glucose concentrations 2.1-2.9 
mM in the first 30 min of cycling (65-70% VO2max) after consuming 75g dextrose, but again 
RPE was not different from PL.  Changes in glucose concentration on account of pre-
exercise carbohydrate consumption appear to occur with mild to no symptoms 
(20,21,22,30,35). 
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Unlike DEX, ingestion of amylomaize-7 starch did not result in serum glucose or 
insulin concentrations different from baseline or PL at any time point.  One could argue that 
a non-insulin-stimulating starch is simply indigestible.  Unmodified high amylose corn starch 
is indeed only 68% digestible (13), but acid/alcohol modification disrupts the exterior of the 
starch granule, partially hydrolyzes glycosidic bonds in the interior, and improves 
digestibility to 92% (10,41).  Work by Johannsen and Sharp (24) verified amylomaize-7 
serves as a combustible substrate for exercise.  During two h of cycling at 65% VO2max, 
carbohydrate oxidation was equally elevated after pre-exercise ingestion of either dextrose or 
amylomaize-7.  Likely due to its slow digestion, amylomaize-7 provided a more sustained 
fuel source; after 90 min, carbohydrate oxidation was higher with amylomaize-7 than 
dextrose.  Unmodified high amylose starch was no different than placebo.  Immediately post-
TT in the present study, lactate concentration averaged 10% higher in the AMY-7 than the 
other two treatments (10.6 mM AMY-7; 9.5mM PL/DEX).  The elevated concentration may 
be attributed to the sustained release of amylomaize-7 (supporting carbohydrate oxidation) or 
simply the higher intensity since the AMY-7 TT tended to be completed the fastest. 
The linear structure of amylomaize-7 is the reason for the minimal insulin response.  
It slows enzymatic digestion, controlling the rate of glucose entry into the blood and reducing 
the amount of insulin needed (2,3,12).  Not only is the insulin peak lowered, the total amount 
of insulin released is reduced.  Granfeldt et al. (12) reported a 42% decrease in the area under 
the curve for insulin when subjects consumed cornbread cakes made from high amylose corn 
starch instead of ordinary corn meal.  In the present study, the mean peak insulin response 
was 70% lower in AMY-7 compared to DEX.  Although digested slowly in the small 
intestine, gastric emptying for amylomaize-7 has been reported to be similar to other 
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maltodextrins (36).  Confirming previous findings (24), subjects did not experience bloating, 
nausea, or abdominal cramps during exercise after ingestion of amylomaize-7. 
Despite the metabolic differences between treatments, endurance performance in the 
present study was unaffected by pre-exercise carbohydrate consumption.  There was a 
tendency for subjects to complete AMY-7 24 s faster than PL and 37 s faster than DEX.  
However, due to variability in the performance trial times (inherent characteristic of human 
performance), the differences did not reach significance.  Based on the statistical power, a 
sample size of 49 would be needed for the difference between to reach significance. 
Rather than doing a TT fixed at 80% Wmax, subjects were allowed to work at a self-
selected intensity to better replicate real-world athletic competition.  Actual mean intensities 
of the TT were 66%, 67%, and 68% Wmax for the dextrose, placebo, and starch trials, 
respectively (range: 59% to 74% Wmax).  In a study where cyclists worked at a higher 
intensity for a longer TT (~75% Wmax for ~40 min), the outcome was the same: 
performance was not significantly affected by pre-exercise carbohydrate ingestion, but the 
dextrose trial (~1 g/kg) averaged 43 s slower than placebo (43:07 ± 1:04 vs 42:34 ± 0:48) 
(20).   
Very different cycling protocols were employed by the studies with conflicting 
conclusions regarding the effect of pre-exercise ingestion on endurance performance.  In 
those finding carbohydrate ingestion to be detrimental (9,25), cyclists rode at a higher 
intensity to exhaustion (80% and 85% VO2max).  At near-maximal intensities, muscle 
substrate stores (i.e. glycogen) become the predominant fuel source (33).  Elevated 
catecholamine levels stimulate glycolysis and inhibit lipolysis.  Hyperinsulinemia further 
increases carbohydrate oxidation, potentially leading to earlier glycogen depletion (11,40).  
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Due to the brevity of the cycling bout in the present study, glycogen stores were not a 
limiting factor in performance.   
A TT preceded by a 90 min submaximal pre-load ride was used in the study finding 
pre-exercise carbohydrate improved performance (11).  Investigators concluded the 
exogenous glucose provided additional substrate for oxidation late in exercise.  Rebound 
hypoglycemia was not a factor in the TT; serum glucose and insulin concentrations had been 
the same for the dextrose and placebo trials for more than 75 min prior to the TT.   
Another investigation also found pre-exercise carbohydrate ingestion improved 
performance (40), but the carbohydrate dose given was five times greater than that of the 
previously mentioned studies (5 g/kg vs ~1 g/kg).  Such variations in carbohydrate type, 
amount, or timing or in the method of performance assessment make it difficult to reach 
conclusions regarding pre-exercise carbohydrate and performance.  In the current study, pre-
exercise carbohydrate consumption did not offer a significant advantage or disadvantage 
during a brief early-exercise TT, compared to water alone. 
In conclusion, rebound hypoglycemia is a consequence of increased glucose uptake 
and suppressed hepatic glucose production during exercise caused by residual insulin from 
pre-exercise carbohydrate ingestion (27).  The present study was designed to maximize the 
chance of rebound hypoglycemia (i.e. carbohydrate dose, timing, exercise intensity) and to 
test performance during that period (brief TT early in exercise).  Yet, clinical hypoglycemia 
was not observed and performance impairment could not be demonstrated.  Pre-exercise 
ingestion of amylomaize-7 instead of dextrose results in more stable serum glucose and 
insulin concentrations, but does not offer an additional performance advantage.   
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APPENDIX 
 
Complete Data Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key 
 
 
 
Treatment 
Name Treatment 
A Dextrose 
B Placebo 
C Starch 
 
 
Time 
Number Name Time from 
Ingestion 
1 Pre-ingestion 0 
2 Pre-exercise 45 
3 Pre-TT 60 
4 Post-TT 75 
5 30min post-exercise 105 
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Table I. Subject characteristics 
 
Subject Height (cm) Weight (kg) BMI (kg/m2) Age (y) 
S1 165.5 58.4 21.3 21 
S2 190.5 80.5 22.2 21 
S3 172.5 70.6 23.7 22 
S4 169.0 66.6 23.3 19 
S5 183.0 76.1 22.7 20 
S6 185.0 90.0 26.3 24 
S7 177.0 74.0 23.6 21 
S8 172.5 69.6 23.4 21 
S9 179.0 72.2 22.5 20 
S10 173.0 59.9 20.0 25 
 
 
 
 
 
 
 
Table II. Self-reported dietary intake for the three days prior to each experimental trial 
 
 Kcal CHO % CHO PRO % PRO FAT % FAT 
S1 2448 271 40% 185 27% 70 23% 
S2 2612 336 49% 113 17% 81 27% 
S3 2427 251 37% 106 15% 44 14% 
S4 3054 314 46% 183 27% 117 38% 
S5 2926 405 59% 97 14% 106 35% 
S6 2783 236 34% 169 25% 126 42% 
S7 3756 275 40% 296 43% 152 50% 
S8 2303 95 14% 256 37% 98 32% 
S9 2676 329 48% 104 15% 107 35% 
S10 3120 406 59% 145 21% 105 34% 
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Table III. Cycling data 
 
Subject VO2max 
(ml/kg/min) 
Wmax 
(W) 
RPMs at 80% L-Factor TT KJ Trial Order 
S1 66.4 300 108 0.0206 216 CBA 
S2 68 400 108 0.0274 288 BAC 
S3   325 93 0.0301 234 ACB 
S4 68.2 350 110 0.0231 252 BAC 
S5 63.6 400 111 0.026 288 CAB 
S6 50.9 425 75 0.0604 306 CBA 
S7 71.9 425 94 0.0385 306 CAB 
S8 64.7 350 100 0.028 252 BAC 
S9 63.9 400 100 0.032 288 CBA 
S10 64 287.5 106 0.0205 207 ACB 
 
Table IV. Time Trial Performance 
 
Subject Treatment 50% Completion (s) 100% Completion (s) 
S1 A 529 1083 
S1 B 497 1018 
S1 C 513 1006 
S2 A 531 1035 
S2 B 537 1091 
S2 C 506 1069 
S3 A 535 1130 
S3 B 572 1163 
S3 C 548 1097 
S4 A 590 1156 
S4 B 530 1132 
S4 C 586 1176 
S5 A 565 1147 
S5 B 559 1146 
S5 C 545 1100 
S6 A 545 1083 
S6 B 551 1111 
S6 C 528 1113 
S7 A 511 1032 
S7 B 517 1032 
S7 C 493 1013 
S8 A 493 1006 
S8 B 478 999 
S8 C 500 1017 
S9 A 589 1226 
S9 B 521 1073 
S9 C 476 973 
S10 A 491 1021 
S10 B 485 1017 
S10 C 475 985 
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Table V. Serum concentration glucose, insulin, and lactate 
 
Subject Treatment Time Glucose  
(mM) 
Insulin 
(µIU/ml) 
Lactate 
(mM) 
S1 A 1 6.1 1.2 1.5 
S1 A 2 10.5 15.0 2.1 
S1 A 3 4.9 2.0 6.2 
S1 A 4 4.7  9.6 
S1 A 5 6.0  2.5 
S1 B 1 6.7 1.4 0.9 
S1 B 2 6.5 1.1 1.4 
S1 B 3 6.2 1.1 3.4 
S1 B 4 6.5  8.9 
S1 B 5 5.5  2.3 
S1 C 1 5.7 1.2 2.4 
S1 C 2 5.5 1.4 1.2 
S1 C 3 4.9 1.1 3.4 
S1 C 4 7.2  10.3 
S1 C 5 5.2  3.4 
S2 A 1 6.0 1.0 1.4 
S2 A 2 6.7 3.1 1.8 
S2 A 3 5.9 1.5 2.3 
S2 A 4 6.8  4.0 
S2 A 5 5.7  1.7 
S2 B 1 5.5 1.1 1.9 
S2 B 2 6.9 1.1 2.2 
S2 B 3 6.1 1.0 1.9 
S2 B 4 5.4  3.2 
S2 B 5 5.6  1.4 
S2 C 1 7.4 1.2 1.2 
S2 C 2 5.8 1.1 1.3 
S2 C 3 6.7 1.4 3.1 
S2 C 4 6.1  3.8 
S2 C 5 6.2  1.4 
S3 A 1 5.0 1.4 3.7 
S3 A 2 9.5 11.7 2.1 
S3 A 3 5.3 1.7 8.1 
S3 A 4 5.1  10.8 
S3 A 5 7.1  3.6 
S3 B 1 6.3 1.4 1.9 
S3 B 2 6.2 1.4 3.2 
S3 B 3 6.3 1.4 4.4 
S3 B 4 7.8  6.8 
S3 B 5 6.8  1.9 
S3 C 1 5.9 1.3 2.9 
S3 C 2 6.1 2.0 2.0 
S3 C 3 5.4 1.4 6.9 
S3 C 4 6.6  9.4 
S3 C 5 6.5  3.5 
S4 A 1 5.8 1.4 3.4 
S4 A 2 9.4 2.2 2.4 
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Subject Treatment Time Glucose  
(mM) 
Insulin 
(µIU/ml) 
Lactate 
(mM) 
S4 A 3 6.3 1.3 4.1 
S4 A 4 7.9  10.6 
S4 A 5 6.6  2.7 
S4 B 1 5.4 1.3 3.7 
S4 B 2 5.6 1.2 1.2 
S4 B 3 5.5 1.3 4.3 
S4 B 4 8.1  14.2 
S4 B 5 5.2  4.3 
S4 C 1 6.8 1.4 1.6 
S4 C 2 7.2 1.5 0.9 
S4 C 3 4.6 1.4 4.1 
S4 C 4 6.2  10.6 
S4 C 5 5.7  3.6 
S5 A 1 5.7 1.4 4.2 
S5 A 2 7.1 4.5 1.5 
S5 A 3 4.9 1.9 6.4 
S5 A 4 4.7  11.9 
S5 A 5 8.4  4.5 
S5 B 1 6.4 1.6 3.3 
S5 B 2 6.9 1.3 1.4 
S5 B 3 6.2 1.3 6.9 
S5 B 4 7.6  13.5 
S5 B 5 7.0  3.5 
S5 C 1 6.1 1.4 2.5 
S5 C 2 6.2 1.4 1.2 
S5 C 3 6.2 1.2 6.0 
S5 C 4 7.5  12.7 
S5 C 5 7.7  3.8 
S6 A 1 6.5 1.2 1.5 
S6 A 2 6.0 2.1 2.2 
S6 A 3 5.1 1.6 7.6 
S6 A 4 5.3  10.6 
S6 A 5 7.8  3.2 
S6 B 1 6.8 1.2 1.2 
S6 B 2 6.9 1.3 1.0 
S6 B 3 5.9 1.3 6.1 
S6 B 4 5.2  9.1 
S6 B 5 5.5  1.9 
S6 C 1 6.4 1.4 1.6 
S6 C 2 6.7 1.4 1.8 
S6 C 3 5.7 1.3 8.1 
S6 C 4 5.6  10.8 
S6 C 5 5.8  2.9 
S7 A 1 5.2 1.4 2.2 
S7 A 2 8.5 12.8 1.4 
S7 A 3 5.0 1.6 2.8 
S7 A 4 5.5  7.3 
S7 A 5 7.9  2.2 
S7 B 1 5.7 1.5 1.9 
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Subject Treatment Time Glucose  
(mM) 
Insulin 
(µIU/ml) 
Lactate 
(mM) 
S7 B 2 5.6 1.4 1.3 
S7 B 3 5.7 1.4 2.1 
S7 B 4 5.7  5.4 
S7 B 5 5.9  2.1 
S7 C 1 5.4 1.4 1.4 
S7 C 2 5.6 1.6 1.4 
S7 C 3 4.8 1.4 2.8 
S7 C 4 7.4  8.6 
S7 C 5 6.8  2.5 
S8 A 1 5.8 1.4 4.5 
S8 A 2 10.9 34.8 1.5 
S8 A 3 4.0 2.1 9.2 
S8 A 4 5.8  16.0 
S8 A 5 7.3  6.3 
S8 B 1 6.3 1.4 4.9 
S8 B 2 6.3 1.4 1.8 
S8 B 3 5.8 1.3 8.3 
S8 B 4 9.8  17.5 
S8 B 5 9.6  6.1 
S8 C 1 6.2 1.4 2.4 
S8 C 2 7.5 1.4 1.4 
S8 C 3 5.1 1.4 8.5 
S8 C 4 8.4  17.7 
S8 C 5 7.4  6.6 
S9 A 1 5.8 1.2 2.1 
S9 A 2 12.1 11.5 1.5 
S9 A 3 6.8 4.8 4.5 
S9 A 4 4.3  5.1 
S9 A 5 8.9  1.8 
S9 B 1 6.5 1.2 2.5 
S9 B 2 6.3 1.2 1.7 
S9 B 3 5.6 1.4 3.3 
S9 B 4 5.7  7.2 
S9 B 5 5.8  2.1 
S9 C 1 6.8 1.0 2.5 
S9 C 2 6.7 1.3 2.1 
S9 C 3 6.2 1.4 3.9 
S9 C 4 6.3  11.8 
S9 C 5 6.0  3.0 
S10 A 1 6.3 1.5 3.1 
S10 A 2 10.5 19.6 2.1 
S10 A 3 4.6 3.4 4.5 
S10 A 4 4.5  7.6 
S10 A 5 9.6  2.8 
S10 B 1 6.3 1.6 1.4 
S10 B 2 6.5 1.6 1.2 
S10 B 3 6.7 1.5 3.9 
S10 B 4 6.3  9.3 
S10 B 5 6.0  2.3 
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Subject Treatment Time Glucose  
(mM) 
Insulin 
(µIU/ml) 
Lactate 
(mM) 
S10 C 1 6.3 1.6 2.8 
S10 C 2 7.0 1.8 1.4 
S10 C 3 6.7 1.6 3.5 
S10 C 4 6.5  10.6 
S10 C 5 5.9  2.4 
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 Table VI. Psychological scale responses 
 
Subject Treatment Time Affect Scale Feeling Scales Rating of 
Perceived 
Exertion 
S1 A 1 1 0  
S1 A 2 1 0  
S1 A 3 1 -1 13 
S1 A 4 2 0 16 
S1 B 1 2 1  
S1 B 2 2 1  
S1 B 3 2 1 10 
S1 B 4 3 1 17 
S1 C 1 2 1  
S1 C 2 2 2  
S1 C 3 2 2 10 
S1 C 4 4 3 16 
S2 A 1 1 1  
S2 A 2 2 2  
S2 A 3 3 3 13 
S2 A 4 4 1 18 
S2 B 1 1 4  
S2 B 2 2 4  
S2 B 3 3 1 13 
S2 B 4 5 -3 17 
S2 C 1 2 2  
S2 C 2 3 2  
S2 C 3 3 1 13 
S2 C 4 2 -1 20 
S3 A 1 3 4  
S3 A 2 1 5  
S3 A 3 4 5 13 
S3 A 4 3 3 17 
S3 B 1 4 4  
S3 B 2 3 3  
S3 B 3 4 3 13 
S3 B 4 5 2 19 
S3 C 1 2 4  
S3 C 2 3 3  
S3 C 3 4 2 11 
S3 C 4 4 1 16 
S4 A 1 1 0  
S4 A 2 1 0  
S4 A 3 3 1 11 
S4 A 4 4 -2 17 
S4 B 1 2 0  
S4 B 2 3 0  
S4 B 3 4 1 13 
S4 B 4 4 -3 17 
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Subject Treatment Time Affect Scale Feeling Scales Rating of 
Perceived 
Exertion 
S4 C 1 1 0  
S4 C 2 2 0  
S4 C 3 3 1 14 
S4 C 4 4 -2 18 
S5 A 1 2 3  
S5 A 2 2 4  
S5 A 3 3 4 8 
S5 A 4 1 2 14 
S5 B 1 2 4  
S5 B 2 3 4  
S5 B 3 3 4 8 
S5 B 4 4 3 15 
S5 C 1 2 3  
S5 C 2 2 4  
S5 C 3 3 3 11 
S5 C 4 4 2 14 
S6 A 1 3 4  
S6 A 2 3 3  
S6 A 3 4 3 13 
S6 A 4 6 3 18 
S6 B 1 2 3  
S6 B 2 2 3  
S6 B 3 4 3 13 
S6 B 4 5 3 17 
S6 C 1 2 4  
S6 C 2 2 4  
S6 C 3 5 4 13 
S6 C 4 6 2 18 
S7 A 1 3 4  
S7 A 2 3 4  
S7 A 3 4 3 12 
S7 A 4 4 2 17 
S7 B 1 3 3  
S7 B 2 4 3  
S7 B 3 4 3 13 
S7 B 4 5 3 16 
S7 C 1 1 3  
S7 C 2 3 3  
S7 C 3 4 3 13 
S7 C 4 4 -1 16 
S8 A 1 5 3  
S8 A 2 5 3  
S8 A 3 5 3 12 
S8 A 4 5 -2 17 
S8 B 1 4 3  
S8 B 2 4 3  
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Subject Treatment Time Affect Scale Feeling Scales Rating of 
Perceived 
Exertion 
S8 B 3 5 1 12 
S8 B 4 6 -2 17 
S8 C 1 5 4  
S8 C 2 6 4  
S8 C 3 5 3 13 
S8 C 4 5 1 17 
S9 A 1 4 4  
S9 A 2 4 4  
S9 A 3 5 4 12 
S9 A 4 5 1 17 
S9 B 1 1 3  
S9 B 2 3 4  
S9 B 3 4 4 12 
S9 B 4 5 3 17 
S9 C 1 5 4  
S9 C 2 5 4  
S9 C 3 6 3 12 
S9 C 4 6 1 18 
S10 A 1 5 3  
S10 A 2 5 3  
S10 A 3 5 3 13 
S10 A 4 4 0 16 
S10 B 1 2 2  
S10 B 2 2 2  
S10 B 3 3 3 14 
S10 B 4 4 1 17 
S10 C 1 3 2  
S10 C 2 3 2  
S10 C 3 4 3 12 
S10 C 4 5 0 16 
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Table VII. Hypoglycemia questionnaire responses 
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S1 A 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 1 1 3 1 1 1 1 1 1 1 2 3 1 
S1 A 5 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 3 1 1 1 1 1 1 1 3 2 1 
S1 B 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 2 1 1 1 1 1 1 1 3 2 1 
S1 B 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 2 1 
S1 C 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 2 1 2 1 1 2 1 1 1 1 3 1 1 
S1 C 5 2 1 1 2 1 1 1 1 1 1 1 2 1 1 2 2 1 3 1 1 1 1 1 1 1 3 2 1 
S2 A 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 3 1 
S2 A 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 4 1 
S2 B 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 1 1 2 1 1 1 1 1 1 1 3 2 1 
S2 B 5 4 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 6 1 1 1 1 1 1 1 6 4 1 
S2 C 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 5 3 1 
S2 C 5 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 6 5 1 
S3 A 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
S3 A 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 
S3 B 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
S3 B 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 1 2 1 1 1 1 1 1 3 2 1 1 
S3 C 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 
S3 C 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 2 1 1 1 1 1 1 2 1 2 1 
S4 A 1 2 1 1 1 1 1 1 2 1 1 1 3 1 1 1 1 1 1 1 1 2 1 1 1 1 2 3 1 
S4 A 5 3 1 1 2 2 1 2 1 1 1 1 2 1 2 2 1 1 3 2 2 1 1 1 3 2 3 3 1 
S4 B 1 3 1 1 1 1 1 2 2 1 1 3 3 1 1 3 1 1 2 1 1 1 1 1 1 1 4 5 1 
S4 B 5 4 2 2 4 2 1 4 4 1 1 1 4 1 5 3 1 1 5 1 3 1 1 1 4 1 6 5 3 
S4 C 1 1 1 2 1 1 1 2 1 1 1 1 2 1 1 2 1 1 2 1 1 1 1 1 1 1 2 2 1 
S4 C 5 3 1 2 3 3 1 3 3 1 1 2 4 1 3 3 3 1 3 1 3 1 2 1 4 2 4 3 2 
S5 A 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 2 1 
S5 A 5 2 1 1 1 1 1 2 1 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 2 1 2 1 
S5 B 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
S5 B 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 2 1 1 1 
S5 C 1 3 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 
S5 C 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 1 2 1 1 1 1 1 1 4 1 2 1 
S6 A 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 2 1 
S6 A 5 4 1 1 3 1 1 1 1 1 1 1 1 1 2 3 5 1 2 1 1 1 1 1 1 5 2 2 1 
S6 B 1 4 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 2 2 1 
S6 B 5 4 1 1 3 1 1 1 1 1 1 1 1 1 2 2 4 1 2 1 1 1 1 1 1 5 1 3 1 
S6 C 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
S6 C 5 5 1 1 3 1 1 1 1 1 1 1 1 1 1 3 5 1 2 1 1 1 1 1 1 5 1 3 1 
S7 A 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5 2 1 
S7 A 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 3 1 1 1 1 1 1 2 5 2 1 
S7 B 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 1 1 
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S7 B 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 3 1 1 1 1 1 1 1 4 1 1 
S7 C 1 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 1 1 
S7 C 5 4 1 1 3 1 1 1 1 1 1 1 1 1 1 1 4 1 4 1 1 1 1 1 1 2 4 1 1 
S8 C 1 2 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 
S8 A 5 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 2 1 1 1 1 2 1 2 3 1 1 
S8 A 1 2 1 1 1 1 1 1 1 1 1 1 4 1 1 1 1 1 1 1 1 1 1 1 1 1 3 3 1 
S8 B 5 4 1 1 2 1 1 1 1 1 1 1 1 1 1 1 3 1 3 1 1 1 1 3 1 1 5 2 1 
S8 B 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 2 1 
S8 C 5 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 3 1 1 1 1 1 1 1 4 2 1 
S8 C 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 
S9 A 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 2 1 1 1 1 1 1 2 2 1 1 
S9 A 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 2 1 
S9 B 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 2 1 1 1 1 1 1 1 2 2 1 
S9 B 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 3 3 1 
S9 C 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 1 2 1 1 1 1 1 1 1 2 2 1 
S9 C 1 2 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 
S10 A 5 3 1 1 3 1 1 3 1 1 1 1 3 1 1 5 2 1 1 1 1 1 3 1 1 1 3 3 1 
S10 A 1 2 1 1 1 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 1 1 1 1 1 3 3 1 
S10 B 5 3 1 1 1 1 1 2 1 1 1 1 2 1 1 2 1 1 3 1 1 1 2 1 1 1 2 2 1 
S10 B 1 2 1 1 1 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 1 1 1 1 1 1 3 2 1 
S10 C 5 4 1 1 2 1 1 3 1 1 1 1 1 1 1 3 1 1 1 1 1 1 3 1 1 1 2 1 1 
 
